2gvc: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /><applet load="2gvc" size="350" color="white" frame="true" align="right" spinBox="true" caption="2gvc, resolution 2.22Å" /> '''Crystal structure of...
 
OCA (talk | contribs)
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Elimination of nonnutritional and insoluble compounds is a critical task, for any living organism. Flavin-containing monooxygenases (FMOs) attach an, oxygen atom to the insoluble nucleophilic compounds to increase solubility, and thereby increase excretion. Here we analyze the functional mechanism, of FMO from Schizosaccharomyces pombe using the crystal structures of the, wild type and protein-cofactor and protein-substrate complexes. The, structure of the wild-type FMO revealed that the prosthetic group FAD is, an integral part of the protein. FMO needs NADPH as a cofactor in addition, to the prosthetic group for its catalytic activity. Structures of the, protein-cofactor and protein-substrate complexes provide insights into, mechanism of action. We propose that FMOs exist in the cell as a complex, with a reduced form of the prosthetic group and NADPH cofactor, readying, them to act on substrates. The 4alpha-hydroperoxyflavin form of the, prosthetic group represents a transient intermediate of the, monooxygenation process. The oxygenated and reduced forms of the, prosthetic group help stabilize interactions with cofactor and substrate, alternately to permit continuous enzyme turnover.
Elimination of nonnutritional and insoluble compounds is a critical task for any living organism. Flavin-containing monooxygenases (FMOs) attach an oxygen atom to the insoluble nucleophilic compounds to increase solubility and thereby increase excretion. Here we analyze the functional mechanism of FMO from Schizosaccharomyces pombe using the crystal structures of the wild type and protein-cofactor and protein-substrate complexes. The structure of the wild-type FMO revealed that the prosthetic group FAD is an integral part of the protein. FMO needs NADPH as a cofactor in addition to the prosthetic group for its catalytic activity. Structures of the protein-cofactor and protein-substrate complexes provide insights into mechanism of action. We propose that FMOs exist in the cell as a complex with a reduced form of the prosthetic group and NADPH cofactor, readying them to act on substrates. The 4alpha-hydroperoxyflavin form of the prosthetic group represents a transient intermediate of the monooxygenation process. The oxygenated and reduced forms of the prosthetic group help stabilize interactions with cofactor and substrate alternately to permit continuous enzyme turnover.


==About this Structure==
==About this Structure==
Line 13: Line 13:
[[Category: Schizosaccharomyces pombe]]
[[Category: Schizosaccharomyces pombe]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Burley, S.K.]]
[[Category: Burley, S K.]]
[[Category: Eswaramoorthy, S.]]
[[Category: Eswaramoorthy, S.]]
[[Category: NYSGXRC, New.York.Structural.GenomiX.Research.Consortium.]]
[[Category: NYSGXRC, New York Structural GenomiX Research Consortium.]]
[[Category: Swaminathan, S.]]
[[Category: Swaminathan, S.]]
[[Category: FAD]]
[[Category: FAD]]
Line 31: Line 31:
[[Category: structural genomics]]
[[Category: structural genomics]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jan 29 20:09:01 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:35:43 2008''